EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World

Autor: Lorenzi, M., Scattolin, D., Del Conte, A., Sangiorgi, S., Polo, V., Pavan, A., Pilotto, S., Santarpia, M., Da Ros, V., Maso, A. Dal, Ferro, A., Frega, S., Bortolami, A., Bonanno, L., Indraccolo, S., Guarneri, V., Pasello, G.
Zdroj: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S450-S451
Databáze: ScienceDirect